2269
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Meiji Holdings Co., Ltd. is a pure holding company that operates through two primary business segments: Food and Pharmaceuticals. The Food segment produces and sells yogurt, milk, beverages, cheese, butter, margarine, cream, ice cream, chocolate, gum, sports nutrition products, infant formula, and feed, under brands including Meiji and D.F. Stauffer. The Pharmaceuticals segment develops and markets human and veterinary medicines through subsidiaries such as Meiji Seika Pharma and Medreich. The group serves markets in Japan, Asia, Europe, and the Americas, with key subsidiaries including Meiji Food Asia Pacific, Meiji America, and Meiji Pharma Spain. The company also maintains equity method affiliates such as CP-MEIJI and Okinawa Meiji Dairy.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Packaged Foods Homepage meiji.com
Sector Consumer Defensive IR page meiji.com
Tags
dairy products, ice cream, chocolate, infant formula, human pharmaceuticals, veterinary medicines, beverages, sports nutrition, Meiji, D.F. Stauffer, Laguna Cookie, Meiji Seika Pharma, Medreich, Adcock Ingram, Inopharm, Meiji Food Asia Pacific, Meiji America, Meiji Pharma Spain, Meiji Seika Europe, Meiji Food Europe, Meiji Food Indonesia, Meiji New Zealand, Meiji Food Vietnam, Meiji Food China, Meiji Dairy Tianjin, Meiji Seika Food Industry Shanghai, Meiji Dairy Suzhou, Meiji Ice Cream Guangzhou, Meiji Food Guangzhou, Taiwan Meiji Food, Meiji Fresh Network, Dohnan Food, Meiji Chewing Gum, Tokai Nuts, Shikoku Meiji, Tokai Meiji, Gunma Meiji, Tochigi Meiji Milk, Meiji Oils, Meiji Seika Singapore, Meiji Food Materials, Meiji Logistics, Nippon Canned Foods, Meiji Feed, Meiji Techno Service, Meiji Nice Day, Meiji Ad Agency, Thai Meiji Food, Meihan Logistics, Meiji Hong Kong, Meiji Food Materials Qingdao, To Transport, Kontor Logistics, New Hokkaido Feed, Makiba Feed, CP-MEIJI, Okinawa Meiji Dairy, Beghin Meiji, Meito Warehouse, Kushiro Feed, Nippon Dairy Trade, Wellnize, Ozawa Pharmaceutical, Me Pharma, Meiji Indonesian Pharmaceutical Industries, Thai Meiji Pharmaceutical
Press page meiji.com/news

Metrics

Valuation  
Market cap ¥ 1.176T
Market cap (USD) $ 7.351B
P/E 26.50
PEG —
P/BV 1.42
P/S 0.98
P/OCF 12.16
P/FCF -160.88
Dividend yield 2.5%
Turnover / mcap —
Returns  
ROE 4.4%
ROI 3.9%
ROIC 5.9%
Profit margin 3.0%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -20.4%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock Yes
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 3
Quality score -11.1%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 1.174T 1.154T 1.105T 1.062T 1.013T 1.192T 1.253T 1.254T 1.241T 1.242T 1.224T 1.161T 1.148T 1.127T
Net profit 35.076B 50.8B 50.675B 69.424B 87.497B 65.655B 67.313B 61.868B 61.278B 60.786B 62.58B 30.891B 19.06B 16.646B
Free cash flow -47.228B 12.356B 57.96B 12.843B 39.206B 60.654B 45.886B 44.854B 38.942B 33.218B 65.077B — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 3.857K 3.25K 3.38K 3.158K 6.613K 7.111K 7.69K 8.998K 8.101K 9.264K 9.053K 7.323K 3.259K 2.181K
Price performance 12m 0.19 -0.04 0.07 -0.52 -0.07 -0.08 -0.15 0.11 -0.13 0.02 0.24 1.25 0.49 —

Filed figures

Figure Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) 184B 196B 202B 180B 178B 348B 346B 404B 379B 391B
↳ YoY growth +1.3% +6.5% +3.3% -11.0% -1.2% +95.7% -0.5% +16.9% -6.3% +3.2%
↳ 5y CAGR -0.4% +13.6% +12.1% +14.9% +16.1% +17.1%
Borrowings, current (JPY) 80.6B 49.7B 33.6B 30.9B 17.3B 28.2B 14.9B 22.3B 25.4B 45.3B
Borrowings, non-current (JPY) 48.9B 69.4B 82.8B 75.9B 84.5B 53B 49.5B 27.6B 22.4B 67.3B
Bonds payable (JPY) 30B 20B 20B 20B 30B 30B 20B 10B 10B 10B
Cash and deposits (JPY) 24.8B 27.6B 25.4B 37.4B 40.3B 67.4B 63.5B 107B 78.2B 69.2B
Intangible assets (JPY) 25.9B 22.6B 13.6B 14B 16B 18.2B 21.5B 21B 19.2B 21.8B
Net debt (borrowings + leases - cash) (JPY) 105B 91.5B 91B 69.3B 61.4B 13.9B 851M -56.9B -30.4B 43.3B
Cash flow detail
Operating cash flow (JPY) 81.9B 109B 112B 114B 124B 128B 85B 108B 69B 56.5B
Purchases of property, plant and equipment (JPY) -48.7B -69.8B -67.2B -68.2B -63B -88.3B -68.8B -50B -52.8B -96.8B
Purchases of intangible assets (JPY) -1.75B -1.94B -4B -2.91B -4.87B -4.85B -3.36B -3.42B -3.83B -6.9B
Change in receivables (cash effect) (JPY) -3.18B -12.7B -773M 20.7B 2.77B 2.9B -5.1B -27.8B 11.4B -2.86B
Change in inventories (cash effect) (JPY) -10.7B -3.31B -4.31B -8.69B -9.56B -5.57B -13.7B 1.96B -11.3B -37.9B
Change in payables (cash effect) (JPY) 5.22B 9.17B 2.14B -11.3B -7.5B 3.68B 9.61B 13.2B -26.2B -3.31B
Dividends paid (cash effect) (JPY) -15.8B -17.8B -19.9B -21B -22.4B -23.9B -24.6B -26.4B -26.8B -27.7B
Interest paid (cash effect) (JPY) -779M -775M -782M -726M -627M -517M -439M -405M -383M -812M
Income taxes paid (cash effect) (JPY) -41.2B -30.6B -32.5B -38.1B -24.5B -41.7B -37.3B -24.8B -32.7B -29.4B
Operating cash flow before change in receivables (JPY) 85.1B 121B 113B 93.4B 121B 125B 90.1B 136B 57.6B 59.4B
Free cash flow (OCF - PPE - intangibles) (JPY) 31.5B 37B 40.9B 43B 55.8B 34.4B 12.8B 54.5B 12.4B -47.2B
Income detail
Research and development expense (JPY) 26.2B 26.5B 29.2B 31.4B 31.4B 33.4B 31B 34.9B 38.9B 37B
↳ 5y CAGR +2.8% +5.0% +3.2% +3.6% +4.3% +3.4%
Total comprehensive income (JPY) 61.8B 70.8B 61.5B 59.4B 85.3B 109B 77.7B 63.4B 56.7B 65.2B
Comprehensive income to owners (JPY) 61.4B 70.1B 59.9B 56.7B 80.7B 104B 75.7B 60.1B 53.5B 61.2B
Provision for credit losses (JPY) — — — 1.1B 1.08B — — — — —
Credit cost ratio (credit losses / average receivables) (%) — — — 0.6% 0.6% — — — — —
Reported Jun 29, 2017 Jun 28, 2018 Jun 27, 2019 Jun 26, 2020 Jun 29, 2021 Jun 29, 2022 Jun 29, 2023 Jun 27, 2024 Jun 26, 2025 Jun 24, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Meiji Holdings Co., Ltd. (ticker 2269), listed in Japan.

ETFs Holding Meiji Holdings Co., Ltd.

ETF Weight in ETF Shares Market value As of
DFIV 0.16% 1,335,722 $ 35.761M Nov 12, 2026
AVDE 0.07% 493,300 $ 14.056M Nov 16, 2026
AVSD 0.07% 9,200 $ 262.136K Nov 16, 2026
DFIC 0.05% 279,834 $ 7.492M Nov 12, 2026
DXIV 0.04% 3,600 $ 96.383K Nov 12, 2026
DFAI 0.03% 222,274 $ 5.951M Nov 12, 2026
DFSI 0.03% 12,900 $ 345.371K Nov 12, 2026
DFAX 0.02% 110,148 $ 2.949M Nov 12, 2026